Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  7,514 results for ""Drug development""

Your Filters

Subject : covid-19
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic.

  • Authors : Sasaki M; Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.; Sato H

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Computer Simulation* ; COVID-19 Drug Treatment*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1372-1382. Date of Electronic Publication: 2024 Mar 05.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

An overview of the development of pharmacotherapeutics targeting SARS-CoV-2.

  • Authors : Lucaj T; Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.; Hay I

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19 Drug Treatment*

  • Source: Drug discovery today [Drug Discov Today] 2024 Sep; Vol. 29 (9), pp. 104126. Date of Electronic Publication: 2024 Aug Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The valley of death: why Australia failed to develop clinically effective drugs in COVID-19.

  • Authors : Martin JH; Clinical Pharmacology and Drug Repurposing and Medicines Research Program, University of Newcastle, Newcastle, New South Wales, Australia.

Subjects: COVID-19* ; Vaccines* ; Antiviral Agents*

  • Source: Internal medicine journal [Intern Med J] 2023 Dec; Vol. 53 (12), pp. 2175-2179. Date of Electronic Publication: 2023 Dec 05.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 Drug Development.

  • Authors : Kim S; Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488 , Republic of Korea.

Subjects: Drug Development* ; COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of microbiology and biotechnology [J Microbiol Biotechnol] 2022 Jan 28; Vol. 32 (1), pp. 1-5.Publisher: Korean Society for Microbiology and Biotechnology Country of Publication: Korea (South) NLM ID: 9431852 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2.

  • Authors : Padroni G; Institute of Biochemistry, Department of Biology, ETH Zurich, Hönggerbergring 64, 8093 Zürich, Switzerland.; Bikaki M

Subjects: COVID-19*/COVID-19*/COVID-19*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/metabolism

  • Source: Nucleic acids research [Nucleic Acids Res] 2023 May 22; Vol. 51 (9), pp. 4555-4571.Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of "co-creation and succeeding together".

  • Authors : Mandal H; The Scientific and Technological Research Council of Turkey, Ankara, Turkey.

Subjects: COVID-19 Vaccines* ; Drug Development*; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: Turkish journal of medical sciences [Turk J Med Sci] 2021 Dec 17; Vol. 51 (SI-1), pp. 3139-3149. Date of Electronic Publication: 2021 Dec 17.Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.

  • Authors : Shimizu T; Early Phase 1 Drug Development Service, Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Kim DW

Subjects: COVID-19* ; Drug Development* ; Neoplasms*/Neoplasms*/Neoplasms*/epidemiology

  • Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Aug; Vol. 17 (4), pp. 388-395. Date of Electronic Publication: 2021 Jan 27.Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic.

  • Authors : Oo C; CO-SunLife Biopharma, NJ, USA; BA-Rutgers Robert Wood Johnson Medical School, NJ, USA. Electronic address: .

Subjects: Drug Development*/Drug Development*/Drug Development*/organization & administration ; Drug Development*/Drug Development*/Drug Development*/trends ; Medical Oncology*/Medical Oncology*/Medical Oncology*/methods

  • Source: Drug discovery today [Drug Discov Today] 2021 Jun; Vol. 26 (6), pp. 1337-1339. Date of Electronic Publication: 2021 Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Model-Informed Drug Development Approaches to Assist New Drug Development in the COVID-19 Pandemic.

  • Authors : Xiong Y; Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Fan J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Models, Biological* ; COVID-19 Drug Treatment*

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Mar; Vol. 111 (3), pp. 572-578. Date of Electronic Publication: 2021 Dec 04.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges.

  • Authors : Aghila Rani KG; Post-doctoral Research Associate, Sharjah Institute of Medical Research, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Hamad MA

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Drug Discovery* ; SARS-CoV-2*

  • Source: Expert opinion on drug discovery [Expert Opin Drug Discov] 2021 Apr; Vol. 16 (4), pp. 365-371. Date of Electronic Publisher: Taylor & Francis Country of Publication: England NLM ID: 101295755 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  7,514 results for ""Drug development""